Treating Alzheimer's and Dementia With D-ribose

To study the effectiveness of d-ribose in treating Alzheimer's and Dementia

Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks to monitor outcomes in a pilot study.

Inclusion Criteria:

• A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance.
• Must have a caregiver living with them.

Exclusion Criteria:

• Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
• Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.